Cargando…

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis

Peripheral blood monocytes include three subsets defined by CD14 and CD16 surface markers. An increase in the CD14(++)CD16(−) classical monocyte fraction ≥ 94% of the total monocytes was proposed to rapidly and efficiently distinguish chronic myelomonocytic leukemia from reactive monocytosis. The ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarfi, Sihem, Harrivel, Véronique, Dumezy, Florent, Guy, Julien, Roussel, Mikael, Mimoun, Aguirre, Fenaux, Pierre, Chapuis, Nicolas, Solary, Eric, Selimoglu-Buet, Dorothée, Wagner-Ballon, Orianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235983/ https://www.ncbi.nlm.nih.gov/pubmed/30429467 http://dx.doi.org/10.1038/s41408-018-0146-8

Ejemplares similares

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia
por: Quang, Violaine Tran, et al.
Publicado: (2023)

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
por: Selimoglu-Buet, Dorothée, et al.
Publicado: (2018)

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2(low) resting monocytes
por: Pronier, Elodie, et al.
Publicado: (2022)

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
por: Merlevede, Jane, et al.
Publicado: (2016)

Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection
por: Favre, Loetitia, et al.
Publicado: (2022)

Tracking chronic myelomonocytic leukaemia diversity at the single cell level
por: Solary, Eric
Publicado: (2020)

Oncogenic Kit Triggers Shp2/Erk1/2 Pathway to Down-Regulate the Pro-Apoptotic Protein Bim and to Promote Apoptosis Resistance in Leukemic Cells
por: Selimoglu-Buet, Dorothée, et al.
Publicado: (2012)

Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia
por: Beke, Allan, et al.
Publicado: (2020)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis
por: Patnaik, M M, et al.
Publicado: (2017)

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
por: Allouch, Awatef, et al.
Publicado: (2022)

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
por: Duchmann, Matthieu, et al.
Publicado: (2018)

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet
por: Itzykson, Raphael, et al.
Publicado: (2018)

Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis
por: Hwang, Sang Mee, et al.
Publicado: (2020)

Chronic myelomonocytic leukemia presenting with polyserositis due to an immune-mediated monocyte activation
por: Imataki, Osamu, et al.
Publicado: (2014)

The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia
por: Murali, Aarya, et al.
Publicado: (2021)

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
por: Duchmann, M, et al.
Publicado: (2017)

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia
por: Pophali, Prateek A., et al.
Publicado: (2019)

Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia
por: Picot, Tiphanie, et al.
Publicado: (2018)

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
por: Valent, Peter, et al.
Publicado: (2019)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
por: Patnaik, M M, et al.
Publicado: (2015)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
por: Patnaik, M M, et al.
Publicado: (2015)

Aging of classical monocyte subsets
por: Goodridge, Helen S.
Publicado: (2023)

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)

Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
Publicado: (1989)

In-Depth Proteomic Characterization of Classical and Non-Classical Monocyte Subsets
por: Segura, Víctor, et al.
Publicado: (2018)

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

Lysozyme nephropathy in chronic myelomonocytic leukemia
por: Patel, Ami B., et al.
Publicado: (2019)

Diagnosis and treatment of chronic myelomonocytic leukemia
por: Kwon, Jihyun
Publicado: (2021)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report
por: Pelkey, Lauren J, et al.
Publicado: (2022)

Non-classical monocytes in tissue injury and cancer
por: Bharat, Ankit, et al.
Publicado: (2017)

METABOLIC FLEXIBILITY IN CLASSICAL MONOCYTES IS NOT AFFECTED BY AGE
por: Yarbro, Johnathan, et al.
Publicado: (2019)

Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series
por: Martin de Frémont, Grégoire, et al.
Publicado: (2021)

Combining imaging flow cytometry and machine learning for high-throughput schistocyte quantification: A SVM classifier development and external validation cohort
por: Demagny, Julien, et al.
Publicado: (2022)

Revising CX3CR1 Expression on Murine Classical and Non-classical Monocytes
por: Meghraoui-Kheddar, Aïda, et al.
Publicado: (2020)

Comprehensive cell surface proteomics defines markers of classical, intermediate and non-classical monocytes
por: Ravenhill, Benjamin J., et al.
Publicado: (2020)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Fighting back against chronic myelomonocytic leukemia
por: Jo, Deog-Yeon
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_md43slf34djojfkklefhdise7j